Eric Alton is Professor of Gene Therapy and Respiratory Medicine, National Heart & Lung Institute, Imperial College London and Honorary Consultant Physician, Royal Brompton Hospital
Professor Alton was educated at Jesus College, Cambridge and Westminster Medical School and subsequently undertook six years of general medical training. Over the last fifteen years, he has been involved in developing gene therapy for cystic fibrosis and angiogenesis, including three clinical trials.
Professor Alton coordinates the UK CF Gene Therapy Consortium which brings together the three centres in the UK (Edinburgh and Oxford Universities and Imperial College), including approximately 80 clinicians and scientists focused on this problem.
et al., Preparation for a first-in-man lentivirus trial in cystic fibrosis patients, Thorax, ISSN:1468-3296
et al., 2017, Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis, Thorax, Vol:72, ISSN:0040-6376, Pages:137-147
et al., 2016, Genetic medicines for CF: Hype versus reality, Pediatric Pulmonology, Vol:51, ISSN:8755-6863, Pages:S5-S17
et al., 2016, METABOLOMIC CHARACTERIZATION OF PSEUDOMONAS AERUGINOSA ISOLATES FROM CYSTIC FIBROSIS PATIENTS USING RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY, Pediatric Pulmonology, Vol:51, ISSN:8755-6863, Pages:312-313
et al., 2016, Preparation for a First-in-Man Lentivirus Trial in Cystic Fibrosis Patients, 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), NATURE PUBLISHING GROUP, Pages:S214-S214, ISSN:1525-0016